Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

CMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings

  Cologuard offers health plans an opportunity to increase screening & improve quality ratings MADISON, Wis., Feb. 2, 2017 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that Cologuard® is included in the Medicare Advantage Advance Notice and Draft Call letter.  Cologuard's inclusion in the final Star Ratings will allow Medicare Advantage plans to increase...Read more

Cologuard Increases Patient Compliance

USMD study highlights opportunity to expand screening & detect curable-stage cancer. Offering Cologuard to Medicare beneficiaries who were previously noncompliant with colon cancer screening was shown to increase screening compliance rates, according to an article published this month in the World Journal of Gastroenterology. The study population comprised Medicare beneficiaries who were at...Read more


View updates on upcoming conference appearances, company news, financial reports and more.

Learn More

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com